首页> 外国专利> Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer's disease treatment

Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer's disease treatment

机译：治疗或预防与阿尔茨海默氏病相关的淀粉样蛋白相关成像异常的方法

页面导航

摘要
著录项
相似文献

摘要

A method of treating or preventing amyloid related imaging abnormalities (ARIA) in patients receiving one or more course of medical treatment for Alzheimer's Disease includes administrating a SUR1-TRPM4 channel inhibitor, such as glyburide, in an amount effective to prevent the formation or reduce the size of one or more ARIAs in the brain.

机译：一种治疗或预防接受阿尔茨海默氏病一个或多个疗程的患者的淀粉样蛋白相关成像异常（ARIA）的方法，包括以有效预防SUR1-TRPM4通道抑制剂（例如格列本脲）的量给药大脑中一个或多个ARIA的大小。

著录项

公开/公告号AU2017301736A1

专利类型
公开/公告日2019-03-14

原文格式PDF
申请/专利权人 BIOGEN CHESAPEAKE LLC;
展开▼

申请/专利号AU20170301736
发明设计人 JACOBSON SVEN;MACALLISTER THOMAS;
展开▼

申请日2017-07-28
分类号A61K31/17;A61K31/18;A61K31/64;A61P25/28;G01N33/15;
国家 AU
入库时间 2022-08-21 11:56:23

相似文献

专利
外文文献
中文文献